Purpose: This study aims to determine the predictive variables of pediatric CD patients who do not reach remission within two years of diagnosis.
Specific Aims: This group of pediatric patients will be compared with CD patients who do go into remission within two years of diagnosis in order to find predictors of (non-) remission, correlations, define 'at risk' patients and asses it’s impact on treatment strategy (drugs, strategy and closer follow-up).
Study Period: April 2023-December 2024
Contact: Gigi Veereman